A detailed history of Delta Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Delta Capital Management LLC holds 9,870 shares of ABBV stock, worth $1.75 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
9,870
Previous 9,870 -0.0%
Holding current value
$1.75 Million
Previous $1.69 Million 15.19%
% of portfolio
0.73%
Previous 0.7%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$154.79 - $180.76 $1,547 - $1,807
-10 Reduced 0.1%
9,870 $1.69 Million
Q4 2023

Jan 25, 2024

SELL
$137.6 - $154.97 $1,376 - $1,549
-10 Reduced 0.1%
9,880 $1.53 Million
Q3 2023

Oct 20, 2023

SELL
$133.59 - $154.65 $72,138 - $83,511
-540 Reduced 5.18%
9,890 $1.47 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $29,152 - $36,278
-220 Reduced 2.07%
10,430 $1.41 Million
Q1 2023

Apr 13, 2023

SELL
$144.61 - $166.54 $8,676 - $9,992
-60 Reduced 0.56%
10,650 $1.7 Million
Q4 2022

Jan 17, 2023

BUY
$138.31 - $165.87 $2,766 - $3,317
20 Added 0.19%
10,710 $1.73 Million
Q2 2022

Jul 15, 2022

BUY
$137.62 - $174.96 $5,504 - $6,998
40 Added 0.38%
10,690 $1.64 Million
Q1 2022

Apr 26, 2022

SELL
$131.98 - $163.75 $245,482 - $304,575
-1,860 Reduced 14.87%
10,650 $1.73 Million
Q4 2021

Jan 31, 2022

BUY
$107.43 - $135.93 $5,908 - $7,476
55 Added 0.44%
12,510 $1.69 Million
Q3 2021

Oct 18, 2021

SELL
$106.4 - $120.78 $1,064 - $1,207
-10 Reduced 0.08%
12,455 $1.34 Million
Q2 2021

Jul 23, 2021

BUY
$105.21 - $117.21 $13,677 - $15,237
130 Added 1.05%
12,465 $1.4 Million
Q1 2021

Apr 23, 2021

BUY
$102.3 - $112.62 $10,230 - $11,262
100 Added 0.82%
12,335 $1.34 Million
Q3 2020

Oct 26, 2020

SELL
$85.91 - $100.83 $25,773 - $30,249
-300 Reduced 2.39%
12,235 $1.07 Million
Q2 2020

Aug 10, 2020

BUY
$73.37 - $98.18 $919,692 - $1.23 Million
12,535 New
12,535 $1.23 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Delta Capital Management LLC Portfolio

Follow Delta Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Capital Management LLC with notifications on news.